Form 4 for AGL agilon health, inc.
Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-14 · accession 0001628280-24-011776 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-18 | 2024-03-14 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | P - Purchase | — | +5,434 | 63.9K | +9% | — | |
| 2024-03-18 | 2024-03-14 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | F - Tax | $5.23 | -1,883 | 62.1K | -3% | -$9,848 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-14 | P | A | 5,434 | — | 63,941 | D | — | — | (F2) The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2021 through December 31, 2023. Total attainment achieved was 100%. (F1) This award was granted on April 14, 2021 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 14, 2024. (F3) Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date. |
| 2 | Common | Common Stock | 2024-03-14 | F | D | 1,883 | $5.23 | 62,058 | D | — | — | (F4) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale. (F5) Includes restricted stock units. |